ERBB2 and breast cancer: Interestingly, such variability can be explained in terms of molecular subtypes of breast cancer [13], namely, for these two miRNAs expression distributions are much less dispersed in each of four subtypes (luminal A, luminal B, HER2 overexpression and basal), see Figure 4.